Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Gepubliceerd in:
hoofdstuk lezen eerste hoofdstuk lezen

2023 | OriginalPaper | Hoofdstuk

6. Radiologie van hoofd en hersenen

Auteurs : Peter Jan van Laar, Olvert A. Berkhemer, Charles B. L. M. Majoie, Diederik W. J. Dippel, Emma E. Wolters, Philip Scheltens, Bart N. M. van Berckel

Gepubliceerd in: De dokter en het beeld

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Inzicht krijgen in de rol van de radiologie in de klinische praktijk van aandoeningen in de neuroradiologie. Kennis verwerven over drie veelvoorkomende aandoeningen in de klinische praktijk waarin de neuroradiologie een essentiële rol speelt. Praktische handvatten voor de betrokken klinische dokter met betrekking tot rol van de neuroradiologie.
vorige hoofdstuk De impact van de musculoskeletale beeldvorming
volgende hoofdstuk Abdominale beeldvorming met een spoedkarakter
Literatuur
1.
2.
3.
Hart- en vaatziekten in Nederland 2016. Den Haag: Hartstichting; 2016.
4.
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929–35.
5.
Dirks M, Niessen LW, Van Wijngaarden JDH, et al. Promoting thrombolysis in acute ischemic stroke. Stroke. 2011;42(5):1325–30.
6.
Thomalla G, Simonsen CZ, Boutitieet F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379(7):611–22.
7.
Del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32(1):78–86.
8.
Beumer D, Saiedie G, Fonville S, et al. Intra-arterial occlusion in acute ischemic stroke: relative frequency in an unselected population. Cerebrovasc Dis. 2013;35(S3):66.
9.
Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.
10.
Goyal M, Menon BK, Van Zwamet WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.
11.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.
12.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708–18.
13.
Mackey J, Kleindorfer D, Sucharewet H, et al. Population-based study of wake-up strokes. Neurology. 2011;76(19):1662–7.
14.
Fink JN, Kumar S, Horkan C, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke. 2002;33(4):988–93.
15.
Jansen IGH, Mulder MJHL, Goldhoorn R-JB, et al. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry). BMJ. 2018;360: k949.
16.
Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670–4.
17.
Yoo AJ,  Berkhemer OA, Fransen PSS, et al. Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurol. 2016;15(7):685–94.
18.
Venema E, Mulder MJHL, Roozenbeek B, et al. Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. BMJ. 2017;357: j1710.
19.
20.
21.
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.
22.
23.
24.
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–77.
25.
Barkhof F, Bastos-Leite AJ, Fox NC, et al. Neuroimaging in dementia. Heidelberg Dordrecht London New york: Springer; 2011.
26.
Harper L, Fumagalli GG, Barkhof F, et al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain. 2016;139:1211–25.
27.
Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med. 2014;55(12):2003–11.CrossRefPubMed
28.
Rabinovici GD, Rosen HJ, Alkalay A, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 2011;77(23):2034–42.
29.
Scheltens P, Zwan M, Ossenkoppele R, et al. Amyloid PET imaging in patients with Alzheimer’s disease. Ned Tijdschr Geneeskd. 2017;161:D808.
30.
Zwan MD, Bouwman FH, Konijnenberg E, et al. Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia. Alzheimers Res Ther. 2017;9(1):2.
31.
Ossenkoppele R, Jansen WJ, Rabinoviciet GD, et al. Prevalence of amyloid PET positivity in dementia syndromes a meta-analysis. JAMA J Am Med Assoc. 2015;313(19):1939–49.
Metagegevens
Titel
Radiologie van hoofd en hersenen
Auteurs
Peter Jan van Laar
Olvert A. Berkhemer
Charles B. L. M. Majoie
Diederik W. J. Dippel
Emma E. Wolters
Philip Scheltens
Bart N. M. van Berckel
Copyright
2023
Uitgeverij
Bohn Stafleu van Loghum
Boek
De dokter en het beeld

Print ISBN: 978-90-368-2869-7

Elektronisch ISBN: 978-90-368-2870-3

Copyright: 2023

DOI
https://doi.org/10.1007/978-90-368-2870-3_6